BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12505115)

  • 1. The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure.
    Sin DD; McAlister FA
    Am J Med; 2002 Dec; 113(8):650-6. PubMed ID: 12505115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.
    Bhatia V; Bajaj NS; Sanam K; Hashim T; Morgan CJ; Prabhu SD; Fonarow GC; Deedwania P; Butler J; Carson P; Love TE; Kheirbek R; Aronow WS; Anker SD; Waagstein F; Fletcher R; Allman RM; Ahmed A
    Am J Med; 2015 Jul; 128(7):715-21. PubMed ID: 25554369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of Utilization of Beta Blockers in Patients With Heart Failure and Depression and Their Effect on Mortality.
    Kim C; Duan L; Phan DQ; Lee MS
    Am J Cardiol; 2019 Sep; 124(5):746-750. PubMed ID: 31277789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomes.
    Tandon P; McAlister FA; Tsuyuki RT; Hervas-Malo M; Dupuit R; Ezekowitz J; Cujec B; Armstrong PW
    Arch Intern Med; 2004 Apr; 164(7):769-74. PubMed ID: 15078647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
    Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
    Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy.
    Cadrin-Tourigny J; Shohoudi A; Roy D; Talajic M; Tadros R; Mondésert B; Dyrda K; Rivard L; Andrade JG; Macle L; Guerra PG; Thibault B; Dubuc M; Khairy P
    JACC Heart Fail; 2017 Feb; 5(2):99-106. PubMed ID: 28089316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction.
    Rochon PA; Tu JV; Anderson GM; Gurwitz JH; Clark JP; Lau P; Szalai JP; Sykora K; Naylor CD
    Lancet; 2000 Aug; 356(9230):639-44. PubMed ID: 10968437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
    Lund LH; Benson L; Dahlström U; Edner M; Friberg L
    JAMA; 2014 Nov; 312(19):2008-18. PubMed ID: 25399276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
    Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial.
    Fiuzat M; Wojdyla D; Pina I; Adams K; Whellan D; O'Connor CM
    JACC Heart Fail; 2016 Feb; 4(2):109-115. PubMed ID: 26519996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the clinical outcome of different beta-blockers in heart failure patients: a retrospective nationwide cohort study.
    Bølling R; Scheller NM; Køber L; Poulsen HE; Gislason GH; Torp-Pedersen C
    Eur J Heart Fail; 2014 Jun; 16(6):678-84. PubMed ID: 24706485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program.
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Am Coll Cardiol; 2008 Jul; 52(3):190-9. PubMed ID: 18617067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta blocker therapy on survival of patients with heart failure and preserved systolic function following hospitalization with acute decompensated heart failure.
    Nevzorov R; Porath A; Henkin Y; Kobal SL; Jotkowitz A; Novack V
    Eur J Intern Med; 2012 Jun; 23(4):374-8. PubMed ID: 22560389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.
    Verbrugge FH; Duchenne J; Bertrand PB; Dupont M; Tang WH; Mullens W
    Am J Cardiol; 2013 Dec; 112(12):1913-20. PubMed ID: 24286620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of beta-blockers to digoxin is associated with improved 1- and 10-year survival of patients hospitalized due to decompensated heart failure.
    Katz A; Maor E; Leor J; Klempfner R
    Int J Cardiol; 2016 Oct; 221():198-204. PubMed ID: 27404675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.
    Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
    Am J Cardiol; 2007 Aug; 100(4):690-6. PubMed ID: 17697830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice.
    Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
    Arch Intern Med; 2008 Dec; 168(22):2415-21. PubMed ID: 19064823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockers in chronic heart failure: considerations for selecting an agent.
    Kukin ML
    Mayo Clin Proc; 2002 Nov; 77(11):1199-206. PubMed ID: 12440556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of beta-blocker use on outcomes after discharge in patients who underwent cardiac surgery.
    Chan AY; McAlister FA; Norris CM; Johnstone D; Bakal JA; Ross DB;
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):182-7, 187.e1. PubMed ID: 20427056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.